Germany · Series A startup

Who invested in Abalos Technologies

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$13Mraised across 1 round since 2019, from 1 source

Latest round
Series A, $13MOct 2019
Led by
Boehringer Ingelheim Venture Fund and Gruenderfonds Ruhr
Investors
4 (2 led)
See who backed them

The rounds

  1. Oct 2019

Everyone who backed them

Boehringer Ingelheim Venture FundCorporate VC1round, led 1
Gruenderfonds RuhrVC firm1round, led 1
nrw.bankVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Abalos Technologies

Who invested in Abalos Technologies?

Abalos Technologies's investors include Boehringer Ingelheim Venture Fund, Gruenderfonds Ruhr, High-Tech Gruenderfonds and nrw.bank. Boehringer Ingelheim Venture Fund led its latest round.

How much has Abalos Technologies raised?

Abalos Technologies has raised $13M across 1 round since 2019.

When did Abalos Technologies last raise?

Abalos Technologies's most recent round was a Series A of $13M in Oct 2019, led by Boehringer Ingelheim Venture Fund.

What was Abalos Technologies's biggest round?

Its most recent round, $13M in Oct 2019, is also its largest on record.

Who backed Abalos Technologies first?

Abalos Technologies's first round on record, in Oct 2019, was backed by Boehringer Ingelheim Venture Fund, Gruenderfonds Ruhr and High-Tech Gruenderfonds and 1 others.

What stage is Abalos Technologies at?

Abalos Technologies's latest named round is a Series A, in Oct 2019.

Where is Abalos Technologies based?

Abalos Technologies is based in Germany.

Who led Abalos Technologies's rounds?

Boehringer Ingelheim Venture Fund led the Series A in 2019.

Companies like Abalos Technologies

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.